VeriMommyricetin sesquicaprylate hamilelikte güvenli mi?
No harmonised CLP classification, no SCCS/CIR reproductive safety assessment located for this ingredient, and the parent compound myricetin lacks consistent evidence of human teratogenicity; published literature on myricetin mainly reports biological activity and some protective/reparative effects in animal models rather than reproductive hazard. Topical esters are expected to have low but measurable dermal absorption; therefore exposure during pregnancy is low but not nil. (Sources: PubMed review on myricetin; cosmetic ingredient databases listing myricetin sesquicaprylate; EWG myricetin page).
Related ingredients
Frequently asked questions
- myricetin sesquicaprylate hamilelikte güvenli mi?
- No harmonised CLP classification, no SCCS/CIR reproductive safety assessment located for this ingredient, and the parent compound myricetin lacks consistent evidence of human teratogenicity; published literature on myricetin mainly reports biological activity and some protective/reparative effects in animal models rather than reproductive hazard. Topical esters are expected to have low but measurable dermal absorption; therefore exposure during pregnancy is low but not nil. (Sources: PubMed review on myricetin; cosmetic ingredient databases listing myricetin sesquicaprylate; EWG myricetin page).
- myricetin sesquicaprylate emzirirken güvenli mi?
- No data found showing reproductive or lactation-specific toxicity or harmonised classification for myricetin sesquicaprylate. Dermal use in nursing parent is expected to give low but measurable exposure; transfer into breastmilk after topical use is unlikely but not studied for this ester specifically.
- myricetin sesquicaprylate bebek cildi için güvenli mi?
- No infant-specific safety studies located for the sesquicaprylate ester. Because infants (0–3 yr) have higher skin permeability and surface‑area‑to‑weight ratio, exposure score is increased by +1 compared with adults (adult e=1 → infant e=2). No evidence was found to indicate the ingredient is a developmental toxin or endocrine disruptor at expected topical exposures.
- VeriMom myricetin sesquicaprylate nasıl puanlıyor?
- VeriMom myricetin sesquicaprylate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte myricetin sesquicaprylate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.